{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:01:51Z","timestamp":1767337311229},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Metast Rev"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/bf00665796","type":"journal-article","created":{"date-parts":[[2004,11,27]],"date-time":"2004-11-27T13:19:11Z","timestamp":1101561551000},"page":"125-148","source":"Crossref","is-referenced-by-count":17,"title":["Murine models of neoplasia: functional analysis of the tumour suppressor genesRb-1 andp53"],"prefix":"10.1007","volume":"14","author":[{"given":"Alan R.","family":"Clarke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.8016642","volume":"265","author":"H Gu","year":"1994","unstructured":"Gu H, Marth JD, Orban PC, Mossman H, Rajewsky K: Science 265: 103?106, 1994","journal-title":"Science"},{"key":"CR2","first-page":"21","volume-title":"Frontiers in pharmacology: Cancer chemotherapy","author":"C Dive","year":"1993","unstructured":"Dive C, Wyllie AH: Apoptosis and Cancer Chemotherapy. In: Hickman JA, Tritton TT (eds) Frontiers in pharmacology: Cancer chemotherapy. Oxford: Blackwell Scientific, pp 21?56, 1993"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/278261a0","volume":"278","author":"DP Lane","year":"1979","unstructured":"Lane DP, Crawford LV: T Antigen is bound to a host protein in SV40 Transformed cells. Nature 278: 261?263, 1979","journal-title":"Nature"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane DP: Cancer:p53, Guardian of the genome. Nature 358: 15?16, 1992","journal-title":"Nature"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","volume":"253","author":"M Hollstein","year":"1991","unstructured":"Hollstein M, Sidransky D, Vogelstein B, Harris CC:p53 Mutations in human cancers. Science 253: 49?53, 1991","journal-title":"Science"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/342705a0","volume":"342","author":"JM Nigro","year":"1989","unstructured":"Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B: Mutations in thep53 gene occur in diverse human tumour types. Nature 342: 705?708, 1989","journal-title":"Nature"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/314633a0","volume":"314","author":"MA Mowat","year":"1985","unstructured":"Mowat MA, Cheng A, Kimura N, Bernstein A, Benchimol S: Rearrangements in the cellularp53 gene in erythroleukemic cells transformed by friend virus. Nature 314: 633?636, 1985","journal-title":"Nature"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/358080a0","volume":"358","author":"JD Oliner","year":"1992","unstructured":"Oliner JD, Kinzler KW, Metzler PS, George DL, Vogelstein B: Amplification of a gene encoding ap53 associated protein in human sarcomas. Nature 358: 80?83, 1992","journal-title":"Nature"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.2218501","volume":"250","author":"O Halevy","year":"1990","unstructured":"Halevy O, Michaloviitz D, Oren M: Different tumor-derivedp53 mutants exhibit distinct biological activities. Science 250: 113?116, 1990","journal-title":"Science"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH: Germ linep53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250: 1233?1238, 1990","journal-title":"Science"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/348747a0","volume":"348","author":"S Srivastava","year":"1990","unstructured":"Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH: Germline transmission of a mutatedp53 gene in a cancerprone family with Li-Fraumeni syndrome. Nature 348: 747?749, 1990","journal-title":"Nature"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.87.12.4766","volume":"87","author":"JR Bischoff","year":"1990","unstructured":"Bischoff JR, Friedman PN, Marshak DR, Prives C, Beach D: Humanp53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc Natl Acad Sci USA 87: 4766?4770, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/j.1460-2075.1990.tb07524.x","volume":"9","author":"DW Meek","year":"1990","unstructured":"Meek DW, Simon S, Kikkawa U, Eckhart W: Thep53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. EMBO J 9: 3253?3260, 1990","journal-title":"EMBO J"},{"key":"CR14","first-page":"6304","volume":"51","author":"MB Kastan","year":"1991","unstructured":"Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation ofp53 protein in the cellular response to DNA damage. Cancer Res 51: 6304?6311, 1991","journal-title":"Cancer Res"},{"key":"CR15","doi-asserted-by":"crossref","unstructured":"Marshall CJ: Tumour suppressor genes. Cell 313?326, 1991","DOI":"10.1016\/0092-8674(91)90641-B"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/366634a0","volume":"366","author":"K Naysmith","year":"1993","unstructured":"Naysmith K, Hunt T: Cell cycle: Dams and sluices. Nature 366: 634?635, 1993","journal-title":"Nature"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1128\/MCB.9.9.3982","volume":"9","author":"A Lavigueur","year":"1989","unstructured":"Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A: High incidence of lung, bone and lymphoid tumours in transgenic mice overexpressing mutant alleles of thep53 oncogene. Mol Cell Biol 9: 3982?3991, 1989","journal-title":"Mol Cell Biol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Bradley A: Mice deficient forp53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215?221, 1992","journal-title":"Nature"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","volume":"362","author":"AR Clarke","year":"1993","unstructured":"Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced byp53-dependent and independent pathways. Nature 362: 849?852, 1993","journal-title":"Nature"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1096\/fasebj.7.10.8344491","volume":"7","author":"M Harvey","year":"1993","unstructured":"Harvey M, McArthur MJ, Montgomery CA, Bradley A, Donehower LA: Genetic background alters the spectrum of tumours that develop inp53-deficient mice. FASEB 7: 938?943, 1993","journal-title":"FASEB"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ng1193-225","volume":"5","author":"M Harvey","year":"1993","unstructured":"Harvey M, McArthur MJ, Montgomery CA, Butel JS, Bradley A, Donehower LA: Spontaneous and carcinogen-induced tumorigenesis inp53-deficient mice. Nature Genetics 5: 225?229, 1993","journal-title":"Nature Genetics"},{"key":"CR22","first-page":"603","volume":"9","author":"CA Purdie","year":"1994","unstructured":"Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SEM, Salter DM, Bird CC, Wyllie AH, Hooper ML, Clarke AR: Tumour incidence, spectrum and ploidy in mice with a large deletion in thep53 gene. Oncogene 9: 603?609, 1994","journal-title":"Oncogene"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","volume":"4","author":"T Jacks","year":"1994","unstructured":"Jacks T, Remington L, Williams BO, Schmitt EM, Halamachi S, Bronson RT, Weinberg RA: Tumour spectrum analysis inp53-mutant mice. Current Biology 4: 1?7, 1994","journal-title":"Current Biology"},{"key":"CR24","first-page":"3313","volume":"8","author":"Y Tsukada Tomooka","year":"1993","unstructured":"Tsukada Tomooka Y, Takai S, Ueda Y, Nishikawa S-I, Yagi T, Tokunaga T, Takeda N, Suda Y, Abe S, Matsuo I, Ikawa Y, Aizawa S: Enhanced proliferative potential in culture of cells fromp53-deficient mice. Oncogene 8: 3313?3322, 1993","journal-title":"Oncogene"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(93)90461-X","volume":"74","author":"CJ Kemp","year":"1993","unstructured":"Kemp CJ, Donehower LA, Bradley A, Balmain A: Reduction ofp53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumours. Cell 74: 813?822, 1993","journal-title":"Cell"},{"key":"CR26","volume-title":"Cocarcinogenesis and biological effects of tumour promoters","author":"E Hecker","year":"1982","unstructured":"Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW: Carcinogenesis: A comprehensive survey. Volume 7. Cocarcinogenesis and biological effects of tumour promoters (New York: Raven Press), 1982"},{"key":"CR27","first-page":"97","volume-title":"Multistage carcinogenesis","author":"A Balmain","year":"1992","unstructured":"Balmain A, Kemp CJ, Burns PA, Stoler AB, Fowlis DJ, Akhurst RJ: Functional loss of tumour suppressor genes in multistage carcinogenesis. In: Harris CC, Hirohashi S, Ito N, Pitot HC, Sugimura T, Terada M, Yokota J (eds) Multistage carcinogenesis. Boca Raton, FL: Japan Scientific Society Press\/CRC Press) 97?108, 1992"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/carcin\/10.4.749","volume":"10","author":"G Furstenberger","year":"1989","unstructured":"Furstenberger G, Schurich B, Kaina B, Petrusevska RT, Fusenig NE, Marks F: Tumour induction in initiated mouse skin by phorbol esters and methyl methanosulphonate: Correlation between chromosomal damage and conversion (?Stage 1 of Tumour Promotion?)in vivo. Carcinogenesis 10: 749?752, 1989","journal-title":"Carcinogenesis"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0092-8674(94)90201-1","volume":"79","author":"A Strasser","year":"1994","unstructured":"Strasser A, Harris AH, Jacks T, Cory S: DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79: 329?339, 1994","journal-title":"Cell"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0092-8674(92)90593-2","volume":"71","author":"MB Kastan","year":"1992","unstructured":"Kastan MB, Zhan Q, El-Diery WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ: A mammalian cell cycle checkpoint pathway utilisingp53 and GADD45 is defective in Ataxia-Telangiectasia. Cell 71: 587?597, 1992","journal-title":"Cell"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1083\/jcb.17.2.299","volume":"17","author":"GJ Todaro","year":"1963","unstructured":"Todaro GJ, Green H: Quantitative studies of the growth of mouse embryos in culture and their development into established lines. J Cell Biol 17: 299?313, 1963","journal-title":"J Cell Biol"},{"key":"CR32","first-page":"2457","volume":"8","author":"M Harvey","year":"1993","unstructured":"Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A, Donehower LA:In vitro growth characteristics of embryo fibroblasts isolated fromp53-deficient mice. Oncogene 8: 2457?2467, 1993","journal-title":"Oncogene"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0092-8674(92)90243-6","volume":"70","author":"LR Livingstone","year":"1992","unstructured":"Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-typep53. Cell 70: 923?935, 1992","journal-title":"Cell"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/356397a0","volume":"356","author":"MC Raff","year":"1992","unstructured":"Raff MC: Social controls on cell survival and cell death. Nature 356: 397?400, 1992","journal-title":"Nature"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JF Kerr","year":"1972","unstructured":"Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. B J Cancer 26: 239?257, 1972","journal-title":"B J Cancer"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-12-364932-4.50010-1","volume":"32","author":"MJ Arends","year":"1991","unstructured":"Arends MJ, Wyllie AH: Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 32: 223?254, 1991","journal-title":"Int Rev Exp Pathol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/carcin\/11.5.847","volume":"11","author":"W Bursch","year":"1990","unstructured":"Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R: Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11: 847?853, 1990","journal-title":"Carcinogenesis"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2249.1994.tb06036.x","volume":"95","author":"SE Howie","year":"1994","unstructured":"Howie SE, Sommerfield AJ, Gray E, Harrison DJ: Peripheral T lymphocyte depletion by apoptosis after CD4 ligationin vivo: selective loss of CD44 and ?activating? memory T cells. Clin Exp Immunol 95: 195?200, 1994","journal-title":"Clin Exp Immunol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/352345a0","volume":"352","author":"E Yonish-Rouach","year":"1991","unstructured":"Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Nature 352: 345?347, 1991","journal-title":"Nature"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/362847a0","volume":"362","author":"SW Lowe","year":"1993","unstructured":"Lowe SW, Schmitt ES, Smith SW, Osborne BA, Jacks T:P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847?849, 1993","journal-title":"Nature"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.4049\/jimmunol.147.12.4286","volume":"147","author":"R Iseki","year":"1991","unstructured":"Iseki R, Mukai M, Iwata M: Signals for the antagonism between activation - and glucocorticoid - induced death. J Immun 147: 4286?4292, 1991","journal-title":"J Immun"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V82.4.1092.1092","volume":"82","author":"J Lotem","year":"1993","unstructured":"Lotem J, Sachs L: Haematopoietic cells from mice deficient in wild-typep53 are more resistant to induction of apoptosis by some agents. Blood 82: 1092?1096, 1993","journal-title":"Blood"},{"key":"CR43","first-page":"307","volume":"8","author":"M Fritsche","year":"1993","unstructured":"Fritsche M, Haessler C, Brandner G: Induction of nuclear accumulation of the tumour suppressor proteinp53 by DNA damaging agents. Oncogene 8: 307?318, 1993","journal-title":"Oncogene"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1101\/gad.7.4.535","volume":"7","author":"SW Lowe","year":"1993","unstructured":"Lowe SW, Ruley HE: Stabilization of thep53 tumour suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes and Development 7: 535?545, 1993","journal-title":"Genes and Development"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","volume":"74","author":"SW Lowe","year":"1993","unstructured":"Lowe SW, Ruley HE, Jacks T, Housman DE:p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957?967, 1993","journal-title":"Cell"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1073\/pnas.91.6.2026","volume":"91","author":"SW Lowe","year":"1994","unstructured":"Lowe SW, Jacks T, Housman DE, Ruley HE: Abrogation of oncogene-associated apoptosis allows transformation ofp53-deficient cells. Proc Natl Acad Sci USA 91: 2026?2030, 1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1073\/pnas.90.12.5742","volume":"90","author":"JM Lee","year":"1993","unstructured":"Lee JM, Bernstein A:p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90: 5742?5746, 1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR48","first-page":"1767","volume":"9","author":"AR Clarke","year":"1994","unstructured":"Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH:p53-dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following ?-irradiation. Oncogene 9: 1767?1773, 1994","journal-title":"Oncogene"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/09553009014552281","volume":"58","author":"CS Potten","year":"1990","unstructured":"Potten CS: A comprehensive study of the radiobiological response of the murine (BDF1) small intestine. Int J Radiat Biol 58: 925?973, 1990","journal-title":"Int J Radiat Biol"},{"key":"CR50","first-page":"614","volume":"54","author":"AJ Merritt","year":"1994","unstructured":"Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, Hall PA: The role ofp53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal andp53 deficient mice. Cancer Res 54: 614?617, 1994","journal-title":"Cancer Res"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1073\/pnas.89.16.7491","volume":"89","author":"SJ Keurbitz","year":"1992","unstructured":"Keurbitz SJ, Plunkett BS, Walsh MV, Kastan MB: Wild typep53 is a cell cycle check-point determinant following irradiation. Proc Natl Acad Sci USA 89: 7491?7495, 1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1073\/pnas.89.16.7742","volume":"89","author":"L Rao","year":"1992","unstructured":"Rao L, Debbas M, Sabbatini P, Hockenberry D, Korsmeyer S: The adenovirus E1a proteins induce apoptosis, which is inhibited by the E1B 19 KDa and bcl-2 proteins. Proc Natl Acad Sci USA 89: 7742?7746, 1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.91.9.3602","volume":"91","author":"X Wu","year":"1994","unstructured":"Wu X, Levine AJ:p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91: 3602?3606, 1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR54","first-page":"771","volume":"49","author":"RB Painter","year":"1986","unstructured":"Painter RB: Int J Radiat Biol 49: 771?781, 1986","journal-title":"Int J Radiat Biol"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1432-1033.1993.tb18130.x","volume":"216","author":"A Lallev","year":"1993","unstructured":"Lallev A, Anachova B, Russev G: Effect of ionizing radiation and topoisomerase II inhibitors on DNA synthesis in mammalian cells. Eur J Biochem 216: 177?181, 1993","journal-title":"Eur J Biochem"},{"key":"CR56","first-page":"317","volume":"21","author":"S Chawlinski","year":"1988","unstructured":"Chawlinski S, Potten CS, Evans G: Double labelling with bromodeoxyuridine (BrdUrd) and 3Hthymidine (3HTdR) of proliferative cells in small intestinal epithelium in steady state and after irradiation cell. Tissue kinet 21: 317?329, 1988","journal-title":"Tissue kinet"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/bjc.1982.87","volume":"45","author":"BL Gallie","year":"1982","unstructured":"Gallie BL, Ellsworth RM, Abramson DH, Phillips RA: Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Brit J Cancer 45: 513?521, 1982","journal-title":"Brit J Cancer"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson","year":"1971","unstructured":"Knudson AG: Proc Natl Acad Sci USA 68: 820?823, 1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/305779a0","volume":"305","author":"WK Cavanee","year":"1983","unstructured":"Cavanee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphee AL, Strong LC, White RL: Expression of recessive alleles by chromosomal mechanisms predisposing to retinoblastoma. Nature 305: 779?784, 1983","journal-title":"Nature"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/323643a0","volume":"323","author":"SH Friend","year":"1986","unstructured":"Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643?646, 1986","journal-title":"Nature"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.3823889","volume":"235","author":"W-H Lee","year":"1987","unstructured":"Lee W-H, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY-HP: Human retinoblastoma susceptibility gene: cloning, identification and sequence. Science 235: 1394?1399, 1987","journal-title":"Science"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1126\/science.3201247","volume":"242","author":"HJ Huang","year":"1988","unstructured":"Huang HJ, Yee JK, Shew JY, Chen PL, Bookstein R, Friedmann T, Lee EY, Lee W-H: Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242: 1563?1566, 1988","journal-title":"Science"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1073\/pnas.88.12.5257","volume":"88","author":"R Takahashi","year":"1991","unstructured":"Takahashi R, Hashimoto T, Xu H-J, Hu S-X, Matsui T, Miki T, Bigo-Marshall H, Aaronson SA, Benedict W: The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sci USA 88: 5257?5261, 1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.2300823","volume":"247","author":"R Bookstein","year":"1990","unstructured":"Bookstein R, Shew J-Y, Chen P-L, Scully P, Lee W-H: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247: 712?715, 1990","journal-title":"Science"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.3175651","volume":"242","author":"T'Ang","year":"1988","unstructured":"T'Ang, Varley JM, Chackraboty S, Murphree AL, Fung TK: Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 242: 263?266, 1988","journal-title":"Science"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.2838909","volume":"241","author":"JW Harbour","year":"1988","unstructured":"Harbour JW, Lai SL, Whang Peng J, Gazdar AD, Minna JD, Kaye FJ: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241: 353?357, 1988","journal-title":"Science"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.2521957","volume":"243","author":"JM Horowitz","year":"1989","unstructured":"Horowitz JM, Yandell DW, Park S-H, Canning S, Whyte P, Buchovitch K, Harlow E, Weinberg RA, Dryja TP: Point mutational inactivation of the retinoblastoma antioncogene. Science 243: 937?940, 1989","journal-title":"Science"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1073\/pnas.87.7.2775","volume":"87","author":"JM Horowitz","year":"1990","unstructured":"Horowitz JM, Park S-H, Bogenmann E, Cheng J-C, Yandell DW, Kaye FJ, Minna JD, Dryja TP, Weinberg RA: Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumour cells. Proc Natl Acad Sci USA 87: 2775?2779, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1073\/pnas.87.19.7762","volume":"87","author":"R Bookstein","year":"1990","unstructured":"Bookstein R, Rio P, Madreperla SA, Hong F, Alfred C, Grizzle WE, Lee W-H: Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87: 7762?7766, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.87.7.2770","volume":"87","author":"Y Furokawa","year":"1990","unstructured":"Furokawa Y, DeCaprio JA, Freedman A, Kanakura Y, Nakamura M, Ernst TJ, Livingstone DM, Griffin JD: Expression and state of phosphorylation retinoblastoma susceptibility gene product in cycling and noncycling human haematopoietic cells. Proc Natl Acad Sci USA 87: 2770?2774, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.3388033","volume":"241","author":"EY-HP Lee","year":"1988","unstructured":"Lee EY-HP, To H, Shew J-Y, Bookstein R, Scully P, Lee W-H: Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241: 218?221, 1988","journal-title":"Science"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/329642a0","volume":"329","author":"W-H Lee","year":"1987","unstructured":"Lee W-H, Shew JY, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee EY-HP: The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 329: 642?645, 1987","journal-title":"Nature"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0959-437X(05)80341-7","volume":"3","author":"RE Hollingsworth","year":"1993","unstructured":"Hollingsworth RE, Hensey CE, Lee W-H: Retinoblastoma protein and the cell cycle. Curr Opin Genet Dev 3: 55?62, 1993","journal-title":"Curr Opin Genet Dev"},{"key":"CR74","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.2588006","volume":"246","author":"K Mihara","year":"1989","unstructured":"Mihara K, Cao X-R, Yen A, Chandler S, Driscoll B, Murphree AL, T'Ang A, Fung Y-KT: Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246: 1300?1303, 1989","journal-title":"Science"},{"key":"CR75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-230X(08)60957-4","volume":"61","author":"E Zacksenhaus","year":"1993","unstructured":"Zacksenhaus E, Bremner R, Jiang Z, Montgomery Gill R, Muncaster M, Sopta M, Phillips RA, Gallie BL: Unraveling the function of the retinoblastoma gene. Advances in cancer research 61: 115?141, 1993","journal-title":"Advances in cancer research"},{"key":"CR76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0092-8674(92)90214-W","volume":"68","author":"S Shirodkar","year":"1992","unstructured":"Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T: The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157?166, 1992","journal-title":"Cell"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1101\/gad.7.12a.2366","volume":"7","author":"Y Li","year":"1993","unstructured":"Li Y, Graham C, Lacy S, Duncan AMV, Whyte P: The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7: 2366?2377, 1993","journal-title":"Genes Dev"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1101\/gad.7.12a.2378","volume":"7","author":"GJ Hannon","year":"1993","unstructured":"Hannon GJ, Demetrick D, Beach D: Isolation of the Rbrelated p130 through its interaction with CDK2 and cyclins. Genes Dev 7: 2378?2391, 1993","journal-title":"Genes Dev"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1101\/gad.7.12a.2392","volume":"7","author":"D Cobrinik","year":"1993","unstructured":"Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA: Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev 7: 2392?2404, 1993","journal-title":"Genes Dev"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/355176a0","volume":"355","author":"L Cao","year":"1992","unstructured":"Cao L, Faha B, Dembski M, Tsai L-H, Harlow E, Dyson N: Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355: 176?179, 1992","journal-title":"Nature"},{"key":"CR81","first-page":"149","volume":"3","author":"L Szekely","year":"1992","unstructured":"Szekely L, Jiang W-Q, Bulic-Jakus F, Rosen A, Ringertz N, Klein G, Wiman KG: Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ 3: 149?156, 1992","journal-title":"Cell Growth Differ"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1073\/pnas.86.17.6474","volume":"86","author":"R Bernards","year":"1989","unstructured":"Bernards Ret al.: Structure and expression of the murine retinoblastoma gene and characterisation of its encoded protein. Proc Natl Acad Sci USA 86: 6474?6478, 1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR83","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","volume":"362","author":"AR Clarke","year":"1992","unstructured":"Clarke AR, Maandag ER, van Roon M, van der Lugt NMT, van der Valk M, Hooper ML, Berns A, te Riele H: Requirement for a functionalRb-1 gene in murine development. Nature 362: 849?851, 1992","journal-title":"Nature"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/359288a0","volume":"359","author":"EY-HP Lee","year":"1992","unstructured":"Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai CC, Herrup K, Lee WH, Bradley A: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288?294, 1992","journal-title":"Nature"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/359295a0","volume":"359","author":"T Jacks","year":"1992","unstructured":"Jacks T, Fazeli A, Schmidt E, Bronson R, Goodell M, Weinberg R: Effects of an Rb mutation in the mouse. Nature 359: 295?300, 1992","journal-title":"Nature"},{"key":"CR86","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1073\/pnas.83.11.3851","volume":"83","author":"PMC Wong","year":"1986","unstructured":"Wong PMC, Chung SW, Chui DHK, Eaves CJ: Properties of the earliest clonogenic hematopietic precursors to appear in the developing murine yolk sac. Proc Natl Acad Sci USA 83: 3851?3854, 1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR87","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0960-9822(93)90347-Q","volume":"3","author":"J Chen","year":"1993","unstructured":"Chen J, Gorman JR, Stewart V, Wiliams B, Jacks T, Alt WA: Generation of normal lymphocyte populations by Rb-deficient embryonic stem cells. Current Biology 3: 405?413, 1993","journal-title":"Current Biology"},{"key":"CR88","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1002\/j.1460-2075.1994.tb06746.x","volume":"13","author":"ECR Maandag","year":"1994","unstructured":"Maandag ECR, van der Valk M, Vlaar M, Feltkamp C, O'Brien J, van Roon MV, van der Lugt N, Berns A, te Riele H: Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J 13: 4260?4268, 1994","journal-title":"EMBO J"},{"key":"CR89","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/j.1460-2075.1994.tb06745.x","volume":"13","author":"BO Williams","year":"1994","unstructured":"Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, Weinberg RA, Jacks T: Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J 13: 4251?4259, 1994","journal-title":"EMBO J"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1101\/gad.8.17.2008","volume":"8","author":"EY-HP Lee","year":"1994","unstructured":"Lee EY-HP, Hu N, Shyng-Shiou FY, Cox LA, Bradley A, Lee W-H, Herrup K: Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes & Dev 8: 2008?2021, 1994","journal-title":"Genes & Dev"},{"key":"CR91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1242\/jcs.1994.Supplement_18.3","volume":"S18","author":"ML Hooper","year":"1994","unstructured":"Hooper ML: The role of thep53 andRb-1 genes in cancer, development and apoptosis. J Cell Sci S18: 13?17 1994","journal-title":"J Cell Sci"},{"key":"CR92","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/343665a0","volume":"343","author":"JJ Windle","year":"1990","unstructured":"Windle JJ, Albert DM, O'Brien JM, Marcus DM, Disteche CM, Bernards R, Mellon PL: Retinoblastoma in transgenic mice. Nature 343: 665?669, 1990","journal-title":"Nature"},{"key":"CR93","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ng0894-480","volume":"7","author":"BO Williams","year":"1994","unstructured":"Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T: Cooperative tumorigenic effects of germline mutations in Rb andp53. Nature Genet 7: 480?484, 1994","journal-title":"Nature Genet"},{"key":"CR94","first-page":"1021","volume":"9","author":"N Hu","year":"1994","unstructured":"Hu N, Gutsmann A, Herbert DC, Bradley A, Lee W-H, Lee Y-HP: HeterozygousRb-1 20\/+ mice are predisposed to tumour of the pituitary gland with a nearly complete penetrance. Oncogene 9: 1021?1027, 1994","journal-title":"Oncogene"},{"key":"CR95","first-page":"1615","volume":"10","author":"DJ Harrison","year":"1995","unstructured":"Harrison DJ, Hooper ML, Armstrong JF, Clarke AR: Effects of heterozygosity for theRb-1 tl9neo allele in the mouse. Oncogene 10: 1615?1620, 1995","journal-title":"Oncogene"},{"key":"CR96","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/339556a0","volume":"339","author":"TP Dryja","year":"1989","unstructured":"Dryja TP, Mukai S, Petersen R, Rapaport JM, Walton D, Yandell DW: Parental origin of mutations of the retinoblastoma gene. Nature 339: 556?558, 1989","journal-title":"Nature"},{"key":"CR97","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/340312a0","volume":"340","author":"X Zhu","year":"1989","unstructured":"Zhu X, Dunn JM, Phillips RA, Goddard AD, Paton KE, Becker A, Gallie BL: Preferential germline mutation of the paternal allele in retinoblastoma. Nature 340: 312?313, 1989","journal-title":"Nature"},{"key":"CR98","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/338156a0","volume":"338","author":"J Toguchida","year":"1989","unstructured":"Toguchida J, Ishizaki K, Sasaki MS, Nakamura Y, Ikenaga M, Kato M, Sugimot M, Kotoura Y, Yamamuro T: Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature 338: 156?158, 1989","journal-title":"Nature"},{"key":"CR99","doi-asserted-by":"crossref","unstructured":"Hammang JP, Baetge EE, Behringer RR, Brinster RL, Palmiter RD, Messing A: Immortalised retinal neurons derived from SV40 T-antigen-induced tumours in transgenic mice. Neuron 4: 775?782","DOI":"10.1016\/0896-6273(90)90204-S"},{"key":"CR100","first-page":"225","volume":"5","author":"F Theuring","year":"1990","unstructured":"Theuring F, Goetz W, Balling R, Korf H-W, Schulze F, Herken R, Gruss P: Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen. Oncogene 5: 225?232, 1990","journal-title":"Oncogene"},{"key":"CR101","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00005072-199007000-00006","volume":"49","author":"H-W Korf","year":"1990","unstructured":"Korf H-W, Goetz W, Herken R, Theuring F, Gruss P, Schachenmayr W: S-antigen and rod-opsin immunoreactions in mid-line brain neoplasms of transgenic mice: similarities to pineal cell tumours and certain medulloblastomas in man. J Neuropath Exp Neurol 49: 424?437, 1990","journal-title":"J Neuropath Exp Neurol"},{"key":"CR102","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.8.11.1300","volume":"8","author":"KA Howes","year":"1994","unstructured":"Howes KA, Ransom N, Papermaster DS, Lasudry JGH, Albert DM, Windle JJ: Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence ofp53. Genes & Dev 8: 1300?1310, 1994","journal-title":"Genes & Dev"},{"key":"CR103","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1101\/gad.8.11.1285","volume":"8","author":"H Pan","year":"1994","unstructured":"Pan H, Griep AE: Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumour suppressor gene function in development. Genes & Dev 8: 1285?1299, 1994","journal-title":"Genes & Dev"},{"key":"CR104","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/371072a0","volume":"371","author":"SD Morgenbesser","year":"1994","unstructured":"Morgenbesser SD, Williams BO, Jacks T, DePinho RA: P-53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72?74, 1994","journal-title":"Nature"},{"key":"CR105","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0092-8674(94)90534-7","volume":"78","author":"H Symonds","year":"1994","unstructured":"Symonds H, Krall L, Remington L, Saenz-Robies M, Lowe S, Jacks T, Van Dyke T:p53-dependent apoptosis suppresses tumor growth and progressionin vivo. Cell 78: 703?711, 1994","journal-title":"Cell"},{"key":"CR106","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0994-66","volume":"8","author":"CJ Kemp","year":"1994","unstructured":"Kemp CJ, Wheldon T, Balmain A:p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genetics 8: 66?69, 1994","journal-title":"Nature Genetics"},{"key":"CR107","first-page":"3731","volume":"9","author":"JM Lee","year":"1994","unstructured":"Lee JM, Abrahamson JLA, Kandel R, Donehower LA, Bernstein A: Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage inp53 deficient mice. Oncogene 9: 3731?3736, 1994","journal-title":"Oncogene"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00665796.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00665796\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00665796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T14:16:02Z","timestamp":1682864162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00665796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["BF00665796"],"URL":"https:\/\/doi.org\/10.1007\/bf00665796","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}